Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
REVISED GMP REGULATION WILL EXEMPT MOST CLASS I DEVICES FROM DESIGN CONTROLS, FDA'S JOHNSON SAYS; ALL CLASS II PRODUCTS WILL FACE DESIGN REQUIREMENTS
Sep 27 1993
More from Archive
More from Medtech Insight